?? ?? Beyond thrilled to announce a strategic investment from Catalyst by Wellstar. Along with their valuable insight into patient care, Starling (YC W22) has the opportunity to pilot within the Wellstar health system. Catalyst by Wellstar is the first of its kind innovation and venture company created by Wellstar – one of the largest health systems in GA. Read more: https://lnkd.in/gCyx2rn4 Come see us at #HLTH next week at their booth 4054!
?? NEW DIRECT INVESTMENT Catalyst by Wellstar is excited to announce our latest strategic investment in Starling (YC W22), a company transforming healthcare with remote urine monitoring technology. Starling Medical’s device uses a predictive algorithm and ultraviolet-visible spectrophotometer to monitor components in urine, enabling early detection and prevention of conditions like urinary tract infections (UTIs). This real-time monitoring solution empowers patients to take control of their health from home while providing vital data to healthcare providers, improving outcomes and reducing hospitalizations, which can be particularly important for elderly or rural patients who may struggle with accessing traditional care settings. #HealthcareInnovation #RemoteMonitoring #PreventativeCare #UTIPrevention #VentureInvestment
